Changes in Myocardial Iron After Iron Administration
Changes in Myocardial Iron Content Following Administration of Intravenous Iron (Myocardial-IRON)
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Listed as NCT03398681, this PHASE4 trial focuses on Heart Failure and Iron-deficiency and remains completed. Sponsored by Fundación para la Investigación del Hospital Clínico de Valencia, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación para la Investigación del Hospital Clínico de Valencia
For direct contact, visit the study record on ClinicalTrials.gov .